Wordt geladen...
Oral verapamil does not affect glucose tolerance in non-diabetics.
Verapamil, a calcium antagonist used to treat angina pectoris, inhibits insulin release in vitro and, when administered intravenously to humans, decreases glucose tolerance. Oral verapamil, 120 mg/day for 1 week increasing thereafter to 240 mg/day in divided doses, was given to nine non-diabetic pat...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
1983
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1427712/ https://ncbi.nlm.nih.gov/pubmed/6860534 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|